Does NADROPARIN Cause Disease recurrence? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disease recurrence have been filed in association with NADROPARIN. This represents 1.6% of all adverse event reports for NADROPARIN.
11
Reports of Disease recurrence with NADROPARIN
1.6%
of all NADROPARIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Disease recurrence From NADROPARIN?
Of the 11 reports, 5 (45.5%) required hospitalization, and 2 (18.2%) were considered life-threatening.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NADROPARIN Cause?
Foetal exposure during pregnancy (81)
Off label use (77)
Premature baby (73)
Maternal exposure during pregnancy (72)
Drug ineffective (54)
Sepsis (46)
Dyspnoea (44)
Fall (43)
Exposure during pregnancy (42)
Confusional state (40)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which NADROPARIN Alternatives Have Lower Disease recurrence Risk?
NADROPARIN vs NAFARELIN
NADROPARIN vs NAFCILLIN
NADROPARIN vs NAFCILLIN\NAFCILLIN
NADROPARIN vs NAFRONYL
NADROPARIN vs NAFTIFINE